Stock SCNI SCINAI IMMUNOTHERAPEUTICS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Scinai Immunotherapeutics Ltd.

Equities

SCNI

US09073Q2049

Market Closed - Nasdaq
Other stock markets
 04:30:01 2024-04-26 pm EDT 		5-day change 1st Jan Change
0.4578 USD +1.74% Intraday chart for Scinai Immunotherapeutics Ltd. -1.76% -23.11%
Apr. 08 Exchange-Traded Funds, Equity Futures Gain Slightly Pre-Bell Monday as June Rate Cut Likelihood Falls MT
Apr. 08 Ayana Pharma Selects Scinai Immunotherapeutics' CDMO Unit to Provide Drug Development and cGMP Manufacturing Services CI

Chart calendar Scinai Immunotherapeutics Ltd.

4.gHFoG6JVNIJNbvT8p-s5b_Ji0QaMKsnCbJu9MMezIgg.-BIjWu9ta-M5WcSt6dMPWrcg5E68Uvz0X8j0U6KHa0rMRwss7zRFyX5fhw~ba1086dac2644b8018e4c2c7d34e9669

Upcoming events on Scinai Immunotherapeutics Ltd.

2024-04-29 Q4 2023 Earnings Release (Projected)
2024-05-29 Q1 2024 Earnings Release (Projected)
2024-08-21 Q2 2024 Earnings Release (Projected)
2024-11-25 Q3 2024 Earnings Release (Projected)

Past events on Scinai Immunotherapeutics Ltd.

2024-04-17 08:45 am Dermatology Drug Development Summit
2024-04-17 05:00 am Dermatology Drug Development Summit
2024-03-17 BioEurope Spring Conference
2024-03-04 MIXiii International Life Science and Health-tech Conference
2024-01-09 10:00 am Business Update Call
2023-11-05 06:00 pm BIO-Europe Conference
2023-10-31 08:23 am Q3 2023 Earnings Release
2023-10-23 06:00 pm CPHI Barcelona Conference
2023-09-12 LSX World Congress
2023-09-10 H.C. Wainwright Global Investment Conference
2023-08-24 09:00 am Annual General Meeting
2023-08-11 09:00 am Q2 2023 Earnings Release
2023-05-15 04:45 pm Q1 2023 Earnings Release
2023-04-17 04:25 pm Q4 2022 Earnings Release
2023-03-21 06:30 am BIO-Europe Spring Conference
2023-02-06 04:15 pm BIO CEO and Investor Conference
2023-01-22 Transdermal and Microneedle Drug Delivery Conference
2023-01-09 12:30 pm Biotech Showcase
2023-01-08 JP Morgan Healthcare Conference
2022-12-13 09:00 am Extraordinary Shareholders Meeting

Annual results

Fiscal PeriodDecember 2018 2019 2020 2021 2022 2023
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00


0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00


0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-21,3
-15,2
-40.25%		-22,7
-19,1
-18.74%		0,00


-10,8
-12,3
11.81%		-11,1
-13,4
17.46%
-10,4

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-24,3
-13,2
-83.83%		-31,6
-19,1
-65.49%		0,00


-12,4
-15,9
21.83%		-5,80
-19,2
69.81%
0,00

Net income
Million USD		Released
Forecast
Spread 		-24,3
-13,2
-83.83%		-31,6
-19,1
-65.49%		-1,36


-12,4
-14,2
12.29%		-5,80
-15,7
63.13%
-7,08

EPS
USD		Released
Forecast
Spread 		-0,94
-0,50
-88.72%		-0,95
-0,60
-57.93%		-1,22


-8,68
-4,20
-106.68%		-4,00
-5,62
28.83%
-1,78

Announcement Date30/04/1912/06/2013/05/2128/03/2217/04/23-

Quarterly results

Fiscal PeriodDecember 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4
Net sales
Million USD		Released
Forecast
Spread


0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread


-3,40
-4,84
29.68%		-2,49
-3,36
25.73%		-3,30
-3,30
-0.02%		1,12
-3,60
131.21%		-6,77
-3,13
-116.64%		-3,19
-2,60
-22.54%		-2,60
-2,80
7.32%		-2,10
-2,70
22.15%
-2,50

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread


-3,34
-6,90
51.55%		-2,83
-3,40
16.72%		-3,93
-3,70
-6.34%		1,09
-4,00
127.21%		-0,57
-4,20
86.48%


-3,76
-2,70
-39.33%		3,11
-3,00
203.57%


Net income
Million USD		Released
Forecast
Spread 		-2,86


-3,34
-4,97
32.76%		-2,83
-3,52
19.64%		-3,93
-3,70
-6.34%		1,09
-4,00
127.21%		-0,57
-4,03
85.89%		-3,52
-2,61
-34.67%		-3,76
-2,85
-32%		3,11
-3,09
200.55%
-2,91

EPS
USD		Released
Forecast
Spread 		-2,53


-2,48
-0,85
-191.79%		-2,39
-1,00
-139.26%		-0,06
-0,10
38.8%		0,03
-0,10
129.1%		0,00
-1,08
- 		-1,20
-0,73
-64.38%		-1,20
-0,91
-31.87%		0,80
-0,94
185.11%
-0,62

Announcement Date30/11/2128/03/2201/06/2225/08/2230/11/2217/04/2315/05/2311/08/2331/10/23-

Upcoming sector events for Scinai Immunotherapeutics Ltd.

Today 04:05 pm QIAGEN N.V.: Q1 2024 Earnings Release
2024-04-29 CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected)
2024-04-30 DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30 PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30 EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30 AZENTA, INC.: Q2 2024 Earnings Release (Projected)
2024-05-01 06:30 am UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release
2024-05-01 06:30 am BIO-TECHNE CORPORATION: Q3 2024 Earnings Release
2024-05-01 07:00 am ALKERMES PLC: Q1 2024 Earnings Release
2024-05-01 VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release
More events

Past sector events for Scinai Immunotherapeutics Ltd.

Today BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q1 2024 Earnings Release (Projected)
Today SINO BIOLOGICAL,INC.: Q1 2024 Earnings Release
Today JOINN LABORATORIES(CHINA)CO.,LTD.: Q1 2024 Earnings Release
Today MORPHOSYS AG: Q1 2024 Earnings Release
2024-04-26 GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release
2024-04-26 GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release
2024-04-26 01:00 am BB BIOTECH AG: Q1 2024 Earnings Release
2024-04-25 BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release
2024-04-25 PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release
2024-04-25 HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected)

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. SCNI Stock
  4. Calendar Scinai Immunotherapeutics Ltd.